Steroid Neuropsychiatric Effects in Medical Illness | MDster You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. Steroid Neuropsychiatric Effects in Transplant and Oncology Care [ Medical Education ](https://mdster.com/blog?category=medical-education) Steroid Neuropsychiatric Effects in Transplant and Oncology Care ================================================================== A practical framework for corticosteroid-induced mania, psychosis, and depression [ MDster Editorial Team ](https://mdster.com/about) · Aug 07, 2026 · 5 min read · 19 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Psychiatry ](https://mdster.com/blog?tag=psychiatry) [ Psychopharmacology ](https://mdster.com/blog?tag=psychopharmacology) [ Consultation-Liaison Psychiatry ](https://mdster.com/blog?tag=consultation-liaison-psychiatry) [ Transplant Psychiatry ](https://mdster.com/blog?tag=transplant-psychiatry) [ Psycho-Oncology ](https://mdster.com/blog?tag=psycho-oncology) [ Corticosteroids ](https://mdster.com/blog?tag=corticosteroids) ![Steroid Neuropsychiatric Effects in Transplant and Oncology Care](https://mdster.com/storage/blog/images/steroid-neuropsychiatric-effects-in-transplant-and-oncology-care.jpg) Share this article Share this post On this page 1. [ Recognize the Syndrome Before Naming It ](#recognize-the-syndrome-before-naming-it) 2. [ Timing and phenotype provide the strongest clues ](#timing-and-phenotype-provide-the-strongest-clues) 3. [ Dose Reduction Versus Symptomatic Treatment ](#dose-reduction-versus-symptomatic-treatment) 4. [ Make this a multidisciplinary decision ](#make-this-a-multidisciplinary-decision) 5. [ Treat the Dominant Syndrome ](#treat-the-dominant-syndrome) 6. [ Mania and psychosis ](#mania-and-psychosis) 7. [ Depression ](#depression) 8. [ Clinical Correlations: Do Not Anchor on Steroids ](#clinical-correlations-do-not-anchor-on-steroids) 9. [ Key Takeaways ](#key-takeaways) 10. [ Conclusion ](#conclusion) 11. [ Frequently Asked Questions ](#blog-faqs) 12. [ References ](#references-heading) On this page 1. [ Recognize the Syndrome Before Naming It ](#recognize-the-syndrome-before-naming-it) 2. [ Timing and phenotype provide the strongest clues ](#timing-and-phenotype-provide-the-strongest-clues) 3. [ Dose Reduction Versus Symptomatic Treatment ](#dose-reduction-versus-symptomatic-treatment) 4. [ Make this a multidisciplinary decision ](#make-this-a-multidisciplinary-decision) 5. [ Treat the Dominant Syndrome ](#treat-the-dominant-syndrome) 6. [ Mania and psychosis ](#mania-and-psychosis) 7. [ Depression ](#depression) 8. [ Clinical Correlations: Do Not Anchor on Steroids ](#clinical-correlations-do-not-anchor-on-steroids) 9. [ Key Takeaways ](#key-takeaways) 10. [ Conclusion ](#conclusion) 11. [ Frequently Asked Questions ](#blog-faqs) 12. [ References ](#references-heading) A transplant recipient receives pulse methylprednisolone for rejection. Four days later, she has stopped sleeping, claims special healing powers, and refuses medication. Calling this “steroid psychosis” is easy; deciding whether to reduce life-preserving immunosuppression is the real consultation-liaison problem. This review reflects evidence available through August 2026. Recognize the Syndrome Before Naming It --------------------------------------- ### Timing and phenotype provide the strongest clues Acute corticosteroid exposure classically produces insomnia, activation, irritability, hypomania, or **mania**. Delusions and hallucinations often occur within a manic syndrome rather than as isolated psychosis. During the first eight weeks, manic symptoms appear more frequently than depressive symptoms; a 2026 meta-analysis estimated psychotic symptoms in approximately 2.4% of users, although certainty was low. [\[1\]](#cite-1 "Reference [1]") Symptoms commonly begin within days to two weeks, but they may emerge after prolonged treatment, dose changes, or discontinuation. Risk rises above approximately 40 mg/day of prednisone equivalent, yet no dose is completely safe. High dose, prolonged exposure, prior psychiatric illness, and older age may increase susceptibility. [\[2\]](#cite-2 "Reference [2]") PresentationTypical cluesImmediate priorityManiaReduced sleep, pressured speech, grandiosity, impulsivityContain risk and restore sleepPsychosisDelusions or hallucinations, often with activationAssess danger and exclude deliriumDepressionDysphoria, anhedonia, withdrawal, suicidalityCheck safety, withdrawal, and adrenal status > **Clinical Pearl:** “Steroid psychosis” is a misleading umbrella term. Identify mania, psychosis, depression, or delirium because each requires different monitoring and treatment. Dose Reduction Versus Symptomatic Treatment ------------------------------------------- ### Make this a multidisciplinary decision Reducing or stopping the corticosteroid is the most direct treatment, but psychiatry should never independently discontinue steroids used for graft rejection, cerebral edema, graft-versus-host disease, or cancer therapy. Use this sequence: 1. **Establish safety.** Address aggression, impaired judgment, suicidality, inability to accept essential care, and severe insomnia. 2. **Verify exposure.** Convert all systemic, injected, and intermittent steroids to prednisone equivalents and map symptoms against dose changes. 3. **Ask whether the steroid remains essential.** Request the lowest effective dose, shortest duration, or an alternative regimen from oncology or transplant specialists. 4. **Treat symptoms concurrently** when reduction is impossible, delayed, or insufficient. Do not confuse psychiatric dose reduction with endocrine tapering. HPA-axis risk depends on dose and duration; abrupt discontinuation after chronic exposure may cause adrenal insufficiency. Current endocrine guidance generally does not require tapering courses shorter than three to four weeks for adrenal protection, although the underlying illness may still require gradual reduction. [\[3\]](#cite-3 "Reference [3]") Treat the Dominant Syndrome --------------------------- ### Mania and psychosis For severe activation, dangerous behavior, or psychosis, use one antipsychotic and titrate cautiously. Risperidone, olanzapine, quetiapine, and haloperidol have supportive case-level evidence, but no regimen has robust randomized-trial validation. Combining steroid reduction with an antipsychotic is the best-supported practical approach. [\[4\]](#cite-4 "Reference [4]") Choose according to the medical context: - Review QTc, potassium, magnesium, antiemetics, antimicrobials, and cancer therapies before prescribing. - Adjust for renal or hepatic dysfunction and start conservatively in frail patients. - Use benzodiazepines briefly for severe insomnia or agitation, but avoid worsening delirium or respiratory compromise. - Avoid carbamazepine when possible in patients receiving tacrolimus, cyclosporine, or sirolimus; CYP3A induction can reduce immunosuppressant exposure. - Be cautious with lithium in AKI or fluctuating volume status and with valproate in thrombocytopenia or hepatic dysfunction. ### Depression Depression is more associated with prolonged exposure, dose reduction, or withdrawal than with the classic early activated state. Assess suicidality directly and distinguish depression from hypoactive delirium, demoralization, cancer-related fatigue, and adrenal insufficiency. Reduce the steroid when medically feasible. Consider an antidepressant for persistent syndromal depression, but first exclude mixed or manic features; antidepressant monotherapy may worsen activation. Severe psychotic depression, catatonia, or life-threatening suicidality warrants urgent specialty treatment rather than watchful waiting. Clinical Correlations: Do Not Anchor on Steroids ------------------------------------------------ In oncology and transplantation, new behavioral symptoms are frequently multifactorial. Check attention, orientation, fluctuation, neurologic findings, medication changes, oxygenation, glucose, electrolytes, renal and hepatic function, and infection markers. Specifically exclude: - Calcineurin-inhibitor neurotoxicity or PRES - CNS infection in an immunocompromised host - Brain metastasis, edema, seizures, or treatment-related neurotoxicity - Opioid, anticholinergic, sedative, or antimicrobial toxicity - Hyperactive or hypoactive delirium Tacrolimus-associated psychosis can occur without classic delirium and even at apparently therapeutic levels; examine the full neurologic picture rather than relying on a trough alone. [\[5\]](#cite-5 "Reference [5]") In cancer patients, medication effects, dehydration, infection, organ failure, and advanced disease remain common reversible contributors to delirium. [\[6\]](#cite-6 "Reference [6]") Key Takeaways ------------- - Acute corticosteroid exposure favors insomnia, mania, and sometimes psychosis; depression is more prominent with chronic exposure or withdrawal. - Dose reduction is first-line when medically safe, but symptomatic treatment is often required simultaneously. - Never stop transplant or oncology steroids without the prescribing team. - Use antipsychotics pragmatically while checking QTc, organ function, cytopenias, and drug interactions. - Treat “steroid-induced” as a hypothesis until delirium, infection, CNS disease, and calcineurin-inhibitor toxicity are excluded. Conclusion ---------- Think in syndromes, not labels. Protect the graft or cancer treatment, reduce corticosteroid burden when possible, and treat dangerous psychiatric symptoms early. Frequently Asked Questions ---------------------------- ### How quickly can psychiatric symptoms begin after corticosteroid initiation? They often begin within days to two weeks, particularly after high-dose systemic therapy, but may occur later or following dose reduction. ### Should corticosteroids be stopped immediately when psychosis develops? Not automatically. Coordinate urgently with oncology or transplant specialists to balance psychiatric severity against rejection, cerebral edema, or other treatment risks. ### Which antipsychotic is preferred for steroid-induced mania or psychosis? No agent is universally preferred. Select based on QTc, organ function, metabolic risk, cytopenias, sedation needs, and interactions with immunosuppressive or oncology drugs. ### How is steroid-induced mania distinguished from delirium? Mania usually has sustained activation, reduced sleep, grandiosity, and pressured speech. Delirium is defined by impaired attention, altered awareness, and fluctuation. ### Is prophylactic psychotropic treatment recommended before steroid re-exposure? Not routinely. Evidence is limited; consider individualized prophylaxis with consultation-liaison psychiatry when prior severe reactions occurred and re-exposure is unavoidable. References (9) ------------------ 1. 1. [ pubmed.ncbi.nlm.nih.gov/42365562 ](https://pubmed.ncbi.nlm.nih.gov/42365562/) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ Gostoli et al. Corticosteroid-Induced Manic and/or Psychotic Symptoms: A Systematic Review. 2025. ](https://pmc.ncbi.nlm.nih.gov/articles/PMC12321511/) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ Endocrine Society: Glucocorticoid-Induced Adrenal Insufficiency Guideline. ](https://www.endocrine.org/clinical-practice-guidelines/glucocorticoid-induced-adrenal-insufficiency) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ Pharmacological Management of Steroid-Induced Psychosis: A Review of Patient Cases. ](https://pmc.ncbi.nlm.nih.gov/articles/PMC7953074/) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ www.sciencedirect.com/science/article/pii/S2667296023001258 ](https://www.sciencedirect.com/science/article/pii/S2667296023001258) [↩](#cite-ref-5-1 "Back to text") 6. 6. [ www.cancer.gov/about-cancer/treatment/side-effects/delirium ](https://www.cancer.gov/about-cancer/treatment/side-effects/delirium) [↩](#cite-ref-6-1 "Back to text") 7. 7. [ Psychiatric Symptoms Associated with Corticosteroid Use: A Systematic Review and Meta-analysis. CNS Drugs, 2026. ](https://link.springer.com/article/10.1007/s40263-026-01298-5) 8. 8. [ Seymour et al. Steroid-Induced Mental Disorders in Oncology Patients. Psycho-Oncology, 2025. ](https://pubmed.ncbi.nlm.nih.gov/40252049/) 9. 9. [ Delayed-Onset Psychosis Secondary to Tacrolimus Neurotoxicity: Systematic Review. ](https://doi.org/10.1016/j.jaclp.2023.09.002) Study pathway Build momentum in Psychiatry with a focused study pathway ----------------------------------------------------------- - Exam‑style questions for Psychiatry - Smart review to target weak topics - Progress tracking that keeps you accountable Free 5-day trial No credit card required. [ Start your free trial ](https://mdster.com/user/dashboard) [ Explore Psychiatry ](https://mdster.com/speciality/psychiatry) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features\*. No commitment. Cancel anytime. \*AI SOE Examiner is limited to 10 cases monthly for Advanced & Bundle subscribers. Explore topics: [ # Psychiatry ](https://mdster.com/blog?tag=psychiatry) [ # Psychopharmacology ](https://mdster.com/blog?tag=psychopharmacology) [ # Consultation-Liaison Psychiatry ](https://mdster.com/blog?tag=consultation-liaison-psychiatry) [ # Transplant Psychiatry ](https://mdster.com/blog?tag=transplant-psychiatry) [ # Psycho-Oncology ](https://mdster.com/blog?tag=psycho-oncology) [ # Corticosteroids ](https://mdster.com/blog?tag=corticosteroids) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Medical Education ------------------------- [ See all ](https://mdster.com/blog?category=medical-education) [### FSH/LH Actions and Ovarian Steroidogenesis: PCOS Explained 5 min read Aug 06, 2026 ](https://mdster.com/blog/fshlh-actions-and-ovarian-steroidogenesis-pcos-explained) [### Trauma-Informed Care in Complex Patients: A Primary Care Guide 5 min read Aug 05, 2026 ](https://mdster.com/blog/trauma-informed-care-in-complex-patients-a-primary-care-guide) [### Sustainability and Spread in Care Pathways: Making Change Stick 6 min read Aug 04, 2026 ](https://mdster.com/blog/sustainability-and-spread-in-care-pathways-making-change-stick) Related Posts ------------- [ ![FSH/LH Actions and Ovarian Steroidogenesis: PCOS Explained](https://mdster.com/storage/blog/images/fshlh-actions-and-ovarian-steroidogenesis-pcos-explained.jpg) Medical Education ### FSH/LH Actions and Ovarian Steroidogenesis: PCOS Explained Master the two-cell, two-gonadotropin model, aromatase physiology, and theca–granulosa signaling—and apply them to PCOS on exams and rounds. 5 min read 0 comments ](https://mdster.com/blog/fshlh-actions-and-ovarian-steroidogenesis-pcos-explained) [ ![Trauma-Informed Care in Complex Patients: A Primary Care Guide](https://mdster.com/storage/blog/images/trauma-informed-care-in-complex-patients-a-primary-care-guide.jpg) Medical Education ### Trauma-Informed Care in Complex Patients: A Primary Care Guide A practical Family Medicine guide to grounding, safer examinations, crisis triage, PTSD-SUD-pain overlap, trauma-focused referrals, and medication pitfalls. 5 min read 0 comments ](https://mdster.com/blog/trauma-informed-care-in-complex-patients-a-primary-care-guide) [ ![Sustainability and Spread in Care Pathways: Making Change Stick](https://mdster.com/storage/blog/images/sustainability-and-spread-in-care-pathways-making-change-stick.jpg) Medical Education ### Sustainability and Spread in Care Pathways: Making Change Stick Learn how to prevent care pathway decay and spread improvement safely through actionable feedback, workflow integration, role-based training, and local adaptation. 6 min read 0 comments ](https://mdster.com/blog/sustainability-and-spread-in-care-pathways-making-change-stick) [ ![Personality Change Due to Another Medical Condition: Clinical Clues](https://mdster.com/storage/blog/images/personality-change-due-to-another-medical-condition-clinical-clues.jpg) Medical Education ### Personality Change Due to Another Medical Condition: Clinical Clues Learn how to recognize acquired personality change, localize frontal-system dysfunction, and distinguish TBI or neurodegeneration from primary psychiatric illness. 5 min read 0 comments ](https://mdster.com/blog/personality-change-due-to-another-medical-condition-clinical-clues) [ ![Complex Family Planning in Restrictive Settings: Harm Reduction & Patient Safety](https://mdster.com/storage/blog/images/complex-family-planning-in-restrictive-settings-harm-reduction-patient-safety.jpg) Medical Education ### Complex Family Planning in Restrictive Settings: Harm Reduction & Patient Safety Learn how to apply harm reduction frameworks, low-test telehealth protocols, and digital privacy measures for complex family planning in restrictive settings. 5 min read 0 comments ](https://mdster.com/blog/complex-family-planning-in-restrictive-settings-harm-reduction-patient-safety) [ ![Care for Complex and Vulnerable Patients in Family Medicine](https://mdster.com/storage/blog/images/care-for-complex-and-vulnerable-patients-in-family-medicine.jpg) Medical Education ### Care for Complex and Vulnerable Patients in Family Medicine Master care coordination, case management, home health eligibility, SUD integration, and IPV protocols for complex and vulnerable patients in primary care. 5 min read 0 comments ](https://mdster.com/blog/care-for-complex-and-vulnerable-patients-in-family-medicine) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept